COMMUNIQUÉS West-GlobeNewswire

Neuralstem Reports Third Quarter 2018 Financial Results and Provides Business Update
14/11/2018
- NSI-189 Received Orphan Designation for Treatment of Angelman Syndrome - - Initiated Phase 2 Clinical Trial of NSI-566 for Treatment of Chronic Stroke - - Second-Generation Neural Stem Cell Program NSI-532 Showed [...]
EDAP TMS SA : EDAP Reports 2018 Third Quarter Results
14/11/2018
Generated revenue growth of more than 14% as compared to the third quarter of 2017 Continued geographic expansion of Focal One with installations in Brazil and South Korea Since receiving FDA clearance for Focal One in [...]
Precision Optics Corporation, Inc. Announces Operating Results for the First Quarter of Fiscal Year 2019 Ended September 30, 2018
14/11/2018
GARDNER, Ma., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB: PEYE) (the “Company”) today announced operating results on an unaudited basis for its first quarter ended September 30, 2018. [...]
ARCA biopharma Announces Third Quarter 2018 Financial Results and Provides Corporate Update
14/11/2018
WESTMINSTER, Colo., Nov. 14, 2018 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for [...]
Avenue Therapeutics Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
14/11/2018
NEW YORK, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (NASDAQ: ATXI) (“Avenue”), a specialty pharmaceutical company focused on the development and commercialization of intravenous (IV) tramadol, today [...]
Vigil Reports Revenue and Earnings Up in Second Quarter
14/11/2018
VICTORIA, British Columbia, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Vigil Health Solutions Inc. (“Vigil”) announces the results of operations for the quarter ending September 30, 2018. Business Highlights Revenue $1.71 [...]
Cytori Reports Q3 2018 Business and Financial Results
14/11/2018
SAN DIEGO, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX) (“Cytori” or the “Company”) today announced Q3 2018 financial results and provided updates on corporate activities. Q3 2018 net loss was $2 [...]
Precision Therapeutics Reports Third Quarter 2018 Financial Results
14/11/2018
MINNEAPOLIS, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]
Syneos Health Announces Corporate Leadership Positions
14/11/2018
Jonathan Olefson Joins as General Counsel and Corporate Secretary Robert Parks Joins as Chief Accounting Officer RALEIGH, N.C., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Syneos Health™ (Nasdaq: SYNH), the only fully integrated [...]
Ascendis Pharma A/S Announces Third Quarter 2018 Financial Results and Business Update Conference Call on November 28
14/11/2018
COPENHAGEN, Denmark, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet medical needs, today [...]
Zosano Pharma Reports Third Quarter 2018 Financial Results and Operational Update
14/11/2018
Selected a contract manufacturer for commercial launch of M207 Completed first required data set in long-term safety study of M207 Appointed Greg Kitchener as Chief Financial Officer FREMONT,Calif., Nov. 14, 2018 (GLOBE [...]
CohBar Reports Third Quarter 2018 Financial Results and Provides Business Update
14/11/2018
Will Host Conference Call on November 14, 2018 at 5:00 p.m. Eastern Time MENLO PARK, Calif., Nov. 14, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria [...]
Aptevo Therapeutics Reports Third Quarter 2018 Financial Results
14/11/2018
Achieves 132% Increase in IXINITY ® Quarterly Net Revenue Year-Over-Year More than Doubles Year-to-Date IXINITY Net Revenue from $8.1 Million to $16.7 Million Advances Bispecifics APVO436 and APVO210; On Track to [...]
AIT Therapeutics Reports Financial Results for Fiscal Second Quarter 2019
14/11/2018
PMA filing for treatment of PPHN expected in calendar second quarter 2019 Pivotal Bronchiolitis trial to initiate in calendar fourth quarter 2019 in the US Positive clinical and pre-clinical data presented at several [...]
Cancer Genetics Appoints Glenn Miles as Chief Financial Officer
14/11/2018
RUTHERFORD, N.J., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics (Nasdaq: CGIX), a leader in enabling precision medicine for immuno-oncology and genomics through molecular markers and diagnostics, today announced the [...]
Helius Medical Technologies, Inc. Announces Proposed Public Offering of Class A Common Stock
14/11/2018
NEWTOWN, Pa., Nov. 14, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”) announced today that it intends to offer and sell, subject to market conditions, [...]
Sienna Senior Living Inc. Reports 2018 Third Quarter Financial Results
14/11/2018
MARKHAM, Ontario, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced its financial results for the three and nine months ended September 30, 2018. The [...]
Pacific Health Care Organization, Inc. Reports Third Quarter 2018 Results
14/11/2018
Newport Beach, CA, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “Commission”) its quarterly report [...]
Active Biotech AB - Interim report January - September 2018
14/11/2018
Third quarter in brief Active Biotech provides update on laquinimod in Huntington's disease Active Biotech regains global rights to the development and commercialization of laquinimod Data from the LEGATO-HD study of [...]

Pages